<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04108221</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A01444-53</org_study_id>
    <nct_id>NCT04108221</nct_id>
  </id_info>
  <brief_title>Study Comparing Two Methods of TransversusAbdominis Plane</brief_title>
  <acronym>CHIRTAP</acronym>
  <official_title>Randomised Study of Noninferiority Comparing a TransversusAbdominis Plane Block Surgical (c-TAP Block) to the Ultrasound-guided Abdominis Plane Block Transversus (Us-TAP Block) in Postoperative Analgesia After Laparoscopy or Laparotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jean-Godinot</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Jean-Godinot</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, randomised, prospective, multicentric study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional, randomised, prospective, multicentric and single blind study&#xD;
&#xD;
      Primary objective :&#xD;
&#xD;
      demonstrate the equivalence of c-TAP Block to us-TAP Block in postoperative analgesia&#xD;
&#xD;
      Secondary objective :&#xD;
&#xD;
        -  Assess the effectiveness of c-TAP block on us-TAP Block in the obese and/or malnourished&#xD;
           patient subgroup&#xD;
&#xD;
        -  Compare the running time of the c-TAP Block to the us-TAP Block&#xD;
&#xD;
        -  Assess the safety of the c-TAP Block gesture in terms of trauma to the intraperitoneal&#xD;
           organs by the injection needle two groups:&#xD;
&#xD;
        -  Arm A : c-TAP Block performed by the surgeon&#xD;
&#xD;
        -  Arm B : us-TAP Block performed by the anesthesist under ultrasound control&#xD;
&#xD;
      Schedule :&#xD;
&#xD;
        -  Inclusions start at: 16/09/2019&#xD;
&#xD;
        -  End date of inclusions: 31/03/2022&#xD;
&#xD;
        -  End date of follow-up: 01/04/2022&#xD;
&#xD;
        -  Study report: 30/09/2022&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>two arms : arm A : c-TAP Block performed by surgeon arm B : us-TAP Block performed by anesthetist</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution pain intensity scores, assessed by the numerical pain scale (EN), postoperative and need for systemic analgesics (intravenously or by mouth) during the 24 hours following the end of the procedure</measure>
    <time_frame>24 hours</time_frame>
    <description>Evolution pain intensity scores, assessed by the numerical pain scale (EN 1 up to 10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Failure rate in the obese and / or malnourished patient subgroup</measure>
    <time_frame>24 hours</time_frame>
    <description>The failure will be defined as follows: a pain evaluated at&gt; 4/10 on EN that requires intravenous or systemic analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in minutes of each of the TAP Block techniques</measure>
    <time_frame>24 hours</time_frame>
    <description>The time will be quantified with a stopwatch. For the c-TAP, the stopwatch will be started as soon as the injection equipment of the locoregional anesthesia is received. For the us-TAP block, the stopwatch will be started after the end of the surgical procedure and as soon as the anesthetist starts to wash his hands to proceed with the injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of trauma to the intra-abdominal organs caused by the injection needle</measure>
    <time_frame>24 hours</time_frame>
    <description>number of traumas that have occurred</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Arm A : c-TAP Block performed by surgeon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>c-TAP Block Block performed by surgeon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B : us-TAP Block performed by anesthetist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>us-TAP Block by anesthetist</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopy or laparotomy withTransversusAbdominis Plane Block</intervention_name>
    <description>The US-TAP is performed by the anesthetist under ultrasound control after the end of the procedure of laparoscopy or laparotomy. Under sterile conditions, the anesthetist identifies the oblique abdominal muscles externally, obliquely internally and transversely by ultrasound. A 20 ml needle of 0.5% ropivacaine is injected.&#xD;
The surgical TAP (c-TAP) block is performed by the surgeon at the end of the procedure of laparoscopy or laparotomy.The needle and the product used are identical to those of the us-TAP block. The positioning of the needle is in the plane of the fascia between the internal oblique muscle and the transverse muscle, identified by a significant loss of resistance.</description>
    <arm_group_label>Arm A : c-TAP Block performed by surgeon</arm_group_label>
    <arm_group_label>Arm B : us-TAP Block performed by anesthetist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patient over 18 years old&#xD;
&#xD;
          -  Patient undergoing laparoscopic or laparotomic abdominal surgery at the investigator&#xD;
             hospital.&#xD;
&#xD;
          -  Patient mastering the French language&#xD;
&#xD;
          -  Patient who received informed information about the study and signed a consent&#xD;
&#xD;
          -  Patient affiliated to a social security scheme.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic pain&#xD;
&#xD;
          -  Patients with opioid dependence&#xD;
&#xD;
          -  Patients allergic to local anesthetic&#xD;
&#xD;
          -  Patient who has not signed the consent of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Christophe EYMARD, PI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut GODINOT</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Koceila AMROUN</last_name>
    <phone>0326504491</phone>
    <email>koceila.amroun@reims.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Sophie MAUBERT, ARC</last_name>
    <phone>0326504184</phone>
    <email>annesophie.maubert@reims.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Godinot</name>
      <address>
        <city>Reims</city>
        <zip>51726</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Sophie MAUBERT, ARC</last_name>
      <phone>0326504184</phone>
      <email>annesophie.maubert@reims.unicancer.fr</email>
    </contact>
    <contact_backup>
      <last_name>sabrina KEMPEN, ARC</last_name>
      <phone>0326504187</phone>
      <email>sabrina.kempen@unicancer.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

